Skip to content
A
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved

Fondazione Michelangelo

OrganisationROR

Trials

  • NCT03595592

    Phase 3Active, not recruiting2018650 people23 Jul 2018clinicaltrials.gov

  • NCT01477060

    Phase 2Terminated201132 people22 Nov 2011clinicaltrials.gov

  • NCT01251107

    Phase 3Completed2000331 people1 Dec 2010clinicaltrials.gov

  • NCT00992030

    Phase 3Terminated2009112 people8 Oct 2009clinicaltrials.gov

© 2026 AgingResearch.News

PrivacyTermsContact

    News

    See all →

    Researchers link Jonathan’s longevity to limited genetic wear

    ResearchGEN and 2 more

    Longevica finds over sixty life-extending compounds in four-year mouse screen

    CompanyLongevity.Technology

    Immune aging accelerates near ages 40 and 60

    ResearchFuturity

    Trials

    See all →

    Registered6 Oct 2026

    AKG and Brain Health in Aging

    Phase 2 · University of Oklahoma

    Registered25 Sept 2026

    The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease

    University Hospital, Akershus

    Registered2 Oct 2026

    Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)

    Phase 1 · Vinmec Research Institute of Stem Cell and Gene Technology

    Trending

    Evidence →
    1. Intervention · 65 papersExercise
    2. Gene · 25 papersAPOE
    3. Disease · 122 papersCardiovascular disease
    4. Process · 127 papersInflammation
    5. Biomarker · 56 papersBody mass index
    6. Intervention · 40 papersSmoking

    Topics

    See all →
    • Mechanisms293
    • Interventions453
    • Biomarkers452
    • Populations573
    • AI & data177
    • Industry & policy22
    • Privacy
    • Terms
    • Contact
    • © 2026 AgingResearch.News